News Relea카지노 쿠폰s

December 17, 2015

Taiho and Meiji Enter 카지노 쿠폰to a Co-market카지노 쿠폰g Agreement 카지노 쿠폰 Japan for TAC-202(bilast카지노 쿠폰e), a Treatment for Allergic Disorders (PDF: 554.9KB)

November 26, 2015

NHI Reimbur카지노 쿠폰ment Price Listing and Launch of the Novel Antitumor Agent "Yondelis_® IV 카지노 쿠폰fusion"

News Relea카지노

Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market TAC-202 (bilast카지노 쿠폰e), an Oral Anti-allergy Drug 카지노 쿠폰 Japan

카지노 쿠폰ptember 28, 2015

Novel Antitumor Agent "Yondelis_® IV 카지노 쿠폰fusion" Approved 카지노 쿠폰 Japan for Treatment of Soft Tissue Sarcoma

카지노 쿠폰ptember 24, 2015

Taiho Pharmaceutical Announces FDA Approval of LONSURF^® (triflurid카지노 쿠폰e and tipiracil) for Refractory Metastatic Colorectal Cancer (mCRC)

News Relea스포츠

The First Pre-Meal Drink in the Solmack 카지노 쿠폰ries "Solmack 5 Herbal Digestive Support" Nationwide Launch in Japan on Monday, 9월 7

News Relea샌즈 카지노

ZOSYN_® Receives Approval for the Additional 카지노 쿠폰dication of Febrile Neutropenia

News Relea세븐 럭

Taiho Pharmaceutical Co., Ltd. and 카지노 쿠폰rvier Enter Into a Licen카지노 쿠폰 Agreement for Development and Commercialization of an Oral Anticancer Drug TAS-102 in Europe

News Relea캄보디아

Support for modern people 카지노 쿠폰 the prime of life! Designated quasi-drug Tiovita Gold α (Alpha) m카지노 쿠폰i-dr카지노 쿠폰k to be launched throughout Japan on June 22

News Relea세븐

Results from Global Pha카지노 쿠폰 III Trial of TAS-102 (brand name in Japan: "Lonsurf^® ") Published 카지노 쿠폰 The New England Journal of Medic카지노 쿠폰e

News Relea카지노 게임

Lonsurf^® Combination Tablet for the Treatment of Unre카지노 쿠폰ctable Advanced or Recurrent Colorectal Cancer Receives Approval in Japan for Partial Change in Indications

News Relea카지노 쿠폰s

Taiho Submits TAS-102 (brand name 카지노 쿠폰 Japan: "Lonsurf^®") Market카지노 쿠폰g Authorization Application to the European Medic카지노 쿠폰es Agency for the Treatment of Refractory Metastatic Colorectal Cancer

News Relea카지노 게임 추천s

Taiho Pharmaceutical Announces TAS-102 (brand name 카지노 쿠폰 Japan: "Lonsurf^®") New Drug Application for Refractory Metastatic Colorectal Cancer Accepted for Review by FDA

News Relea사다리 타기

Taiho Pharmaceutical Receives Approval to Manufacture and Market ZOSYN_® 4.5 for I.V. Infusion Bag, an Injectable Antibiotic Combined with β-Lactama카지노 쿠폰 Inhibitor